Clinical trial · Interventional
Evaluating the Efficacy of the eNav Toolkit to Improve Colorectal Cancer Screening
Developing and Testing a Digital Toolkit to Improve Colorectal Cancer Screening Rates in Federally Qualified Health Centers
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this research study is to evaluate the efficacy of a digital navigation tool, called the eNav to improve colorectal cancer screening uptake among patients treated at federally qualified health centers (FQHC)s. The digital navigation tool includes a website and text messaging support. The website includes information, motivational support, decisional support and cues to action (e.g., ability to request a CRC screening test). The eNav tool also includes text-messaging based navigation (e.g., reminders, instructions to complete the screening test).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer Screening | Colorectal Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| eNav | Other | — | UNRESOLVED |
| Standard of Care | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- eNav intervention
- description
- Subjects assigned to this arm will receive a link to the eNav website.
- interventionNames
- Other: eNav
- type
- PLACEBO_COMPARATOR
- label
- Usual Care Group
- description
- Subjects assigned to this arm will not receive the link to the website and will receive standard clinical care.
- interventionNames
- Other: Standard of Care
Primary outcomes (1)
- measure
- Colorectal Cancer (CRC) Screening completion
- timeFrame
- End of study, at 6 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 45 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Patient treated at the Institute for Family Health (IFH) * Patient 45 to 75 years old * English or Spanish speaking * Able to provide consent within the study time frame (within a month of the primary care appointment * Patients have access to a computer, tablet or mobile device to access the eNav Toolkit OR willing to use a clinic provided device, in person at either IFH OR Mount Sinai * Patient scheduled for a primary care appointment at IFH * Patients are due for colorectal cancer screening (as determined by the health maintenance alert in the medical chart) Exclusion Criteria: * Unable to provide informed consent
References
Publications (0)
Data not yet available